DarioHealth Corp. Warrant
DRIOW
DRIOW was delisted on the 4th of March, 2021.
1 hedge funds and large institutions have $18K invested in DarioHealth Corp. Warrant in 2017 Q4 according to their latest regulatory filings, with 0 funds opening new positions, 1 increasing their positions, reducing their positions, and 1 closing their positions.
22% less capital invested
Capital invested by funds: $23K → $18K (-$5K)
50% less funds holding
Funds holding: 2 → 1 (-1)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 1
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
+$191 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
WPC
Waters Parkerson & Co
New Orleans,
Louisiana
|
-$5K |
DRIOW Hedge Fund Activity: Q4 2017 in Review
1 of the 4,410 institutional investors tracked by Wall St. Rank reported a position in DarioHealth Corp. Warrant (DRIOW) for Q4 2017, worth a combined $18K — down 22% from $23K a quarter earlier.
Sellers outnumbered buyers: 1 fund closed out of DRIOW and 0 opened new positions — a net loss of 1 holder — while 0 trimmed existing stakes and 1 added.
The largest buyer was UBS Group, adding an estimated $191. The largest seller was Waters Parkerson & Co, exiting entirely with an estimated $5K sold.
- 1 institutional investor held DarioHealth Corp. Warrant (DRIOW) as of Q4 2017, down from 2 in Q3 2017.
- Funds reported $18K of DarioHealth Corp. Warrant stock for Q4 2017, down 22% quarter-over-quarter.
- 0 funds opened new DarioHealth Corp. Warrant positions in Q4 2017 and 1 closed out, a net change of -1 holder.
- The largest DarioHealth Corp. Warrant buyer in Q4 2017 was UBS Group, an estimated $191 added.
- The largest DarioHealth Corp. Warrant seller in Q4 2017 was Waters Parkerson & Co, an estimated $5K sold.
Based on aggregated 13F filings for Q4 2017.